Stay updated on Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial
Sign up to get notified when there's something new on the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page.

Latest updates to the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe record history now shows a new revision entry v3.6.6, replacing the previous v3.6.5 entry. This updates the study's revision history to reflect a latest change to the record.SummaryDifference0.1%

- Check28 days agoChange DetectedA new version entry (32) was added to the Record History, introducing Contacts/Locations and Study Status sections for the study record. This updates how changes to the record are tracked and displayed.SummaryDifference0.4%

- Check42 days agoChange DetectedA new revision tag v3.6.5 was added to the record history, replacing the previous v3.6.4, indicating an updated version of the study record. This change updates the record's metadata rather than trial data or outcomes.SummaryDifference0.1%

- Check56 days agoChange DetectedThe study record's revision history gains a new entry for v3.6.4 and removes the previous v3.6.3 entry, indicating an update to the page's revision history.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision entry, v3.6.3, was added to the record history. The previous revision, v3.6.2, was removed from the list.SummaryDifference0.1%

- Check85 days agoChange DetectedA new revision entry, v3.6.2, was added to the study history and the earlier revision v3.6.0 was removed, updating the historical log displayed on the page.SummaryDifference0.1%

Stay in the know with updates to Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page.